Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes
Year: 2018
Type: article
Abstract: The liver is an organ with strong regenerative capacity, yet primary hepatocytes have a low amplification potential in vitro, a major limitation for the cell-based therapy of liver disorders and for ex vivo biological screens. Induced pluripotent stem cells (iPSCs) may help to circumvent this obstacle but often harbor genetic and epigenetic abnormalities, limiting their potential. Here, we describe the pharmacological induction of proliferative human hepatic progenitor cells (HPCs) through a cocktail of growth factors and small molecules mimicking the signaling events involved in liver regeneration. Human HPCs from healthy donors and pediatric patients proliferated vigorously while maintaining their genomic stability and could be redifferentiated in vitro into metabolically competent cells that supported the replication of hepatitis B and delta viruses. Redifferentiation efficiency was boosted by three-dimensional culture. Finally, transcriptome analysis showed that HPCs were more closely related to mature hepatocytes than iPSC-derived hepatocyte-like cells were. Conclusion: HPC induction holds promise for a variety of applications such as ex vivo disease modeling, personalized drug testing or metabolic studies, and development of a bioartificial liver.
Source: Hepatology
DOI: 10.1002/hep.30425
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,900
Funders: National Science Foundation, Styrelsen för Internationellt Utvecklingssamarbete, Novartis Foundation, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, École Polytechnique Fédérale de Lausanne, Louis-Jeantet Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Labex, Université de Genève, Université de Lausanne, École Normale Supérieure de Lyon, Laboratoire d'Excellence Ecofect, H2020 Marie Skłodowska-Curie Actions, FP7 Ideas: European Research Council, FP7 People: Marie-Curie Actions
Awards: G1593322884, G3785575267, Molecular Analysis of Hepatitis C Virus Neutralization and Entry For the Development of Novel Antiviral Immunopreventive Strategies, Dynamiques eco-évolutives des maladies infectieuses, KRAB/KAP1-mediated gene regulation in mammalian physiology and human diseases, G6634568861
OpenAlex ID: W2904633962
